ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Translational and Clinical Endocrinology
Functional analysis from ex-vivo characterization of LDLR exon 13-15 duplication associated to Familial Hypercholesterolemia
Provisionally accepted
Catalina Martínez1Carolina Alarcón1Andrea Cid2Noemí Vilches2Claudia Radojkovic1
Enrique Guzmán-Gutiérrez1Katia Saez1Rodrigo Alonso3
Andrea Sanchez1*- 1Faculty of Pharmacy, Universidad de Concepción, Concepcion, Chile
- 2Universidad de Concepcion, Concepción, Chile
- 3center for advanced metabolic Medicine and Nutrition, Santiago, Chile
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Familial hypercholesterolemia (FH) is an inherited semidominant disorder characterized by high plasma cholesterol levels and increased risk of premature cardiovascular disease. More than 3,000 low-density lipoprotein receptor (LDLR) variants have been identified, most lack functional evidence to determine their pathogenicity. One of them is the exon13_15dup, the most frequent FH-causing variant in Chile. However, its functional impact is poorly understood. Objective: To determine the functional impact of the exon13_15dup variant in the LDLR, in familial hypercholesterolemia patients. Methods: Three heterozygous carriers of an exon 13-15 duplication and five wild type subjects were recruited. The peripheral blood mononuclear cells were isolated and differentiated to macrophages. The LDLR expression levels on the cell membrane were evaluated by flow cytometry, subcellular localization by confocal microscopy and LDL incorporation by LDL-FITC uptake assays. Results. The exon13_15dup variant leads to significantly increased cell-surface LDLR expression and enhanced localization in the endoplasmic reticulum. This results in a reduced capacity for LDL uptake in patient cells, with principal component analysis highlighting distinct differences in LDLR localization compared to wild-type samples. Conclusions: The functional analysis showed that the mutation affects the proper transport and function of LDLR, resulting in a dysfunctional protein that cannot effectively internalize LDL.
Keywords: Ex vivo Characterization, Exon13_15dup, Familial Hypercholesterolemia, Functional assays, human macrophages
Received: 27 Oct 2025; Accepted: 29 Jan 2026.
Copyright: © 2026 Martínez, Alarcón, Cid, Vilches, Radojkovic, Guzmán-Gutiérrez, Saez, Alonso and Sanchez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Andrea Sanchez
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.